Implementation of individualised polygenic risk score analysis: a test case of a family of four
Manuel Corpas1,2,3, Karyn Megy4,5, Antonio Metastasio4,6
1Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, Cambridge, UK. m.corpas@cpm.onl.
Insights
Polygenic risk scores (PRS) can stratify populations by disease risk. However, implementing PRS for individual risk assessment in healthcare requires further standardization and validation for accurate clinical translation.
Area of Science:
- Genomics
- Computational Biology
- Precision Medicine
Background:
- Polygenic risk scores (PRS) are utilized in research to stratify populations by disease risk.
- Healthcare systems are exploring PRS for population health management.
- Limited research exists on implementing PRS at an individual level.
Observation:
- 15 PRS phenotypes (cancer, cardiovascular, metabolic, autoimmune) were curated, utilizing over 37 million SNPs.
- Whole genome sequencing data from a family of four was used for phenotype testing.
- Individual PRS were calculated and assigned percentile values against reference populations (1000 Genomes Iberians, Europeans, or all samples).
Findings:
- Over 96 billion allele effects were computed to derive individual PRS.
- Results underscore the necessity for standardized PRS development and data sharing.
- Individual risk assessment is crucial, moving beyond generalized population averages.
Implications:
- Translating PRS into actionable clinical risk metrics presents current challenges.
- Standardization is key for the reliable clinical application of PRS.
- Future work should focus on refining PRS for individual-level predictive accuracy in healthcare.
Background:
Polygenic risk scores (PRS) have been widely applied in research studies, showing how population groups can be stratified into risk categories for many common conditions. As healthcare systems consider applying PRS to keep their populations healthy, little work has been carried out demonstrating their implementation at an individual level.
Case Presentation:
We performed a systematic curation of PRS sources from established data repositories, selecting 15 phenotypes, comprising an excess of 37 million SNPs related to cancer, cardiovascular, metabolic and autoimmune diseases. We tested selected phenotypes using whole genome sequencing data for a family of four related individuals. Individual risk scores were given percentile values based upon reference distributions among 1000 Genomes Iberians, Europeans, or all samples. Over 96 billion allele effects were calculated in order to obtain the PRS for each of the individuals analysed here.
Conclusions:
Our results highlight the need for further standardisation in the way PRS are developed and shared, the importance of individual risk assessment rather than the assumption of inherited averages, and the challenges currently posed when translating PRS into risk metrics.
More Related Videos
Related Concept Videos
Polygenic Traits
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Probability Laws
Relative Risk
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Single Nucleotide Polymorphisms-SNPs


